Cite
Pilgrim T, Vollenbroich R, Deckarm S, et al. Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2021;6(10):1171-1176doi: 10.1001/jamacardio.2021.2247.
Pilgrim, T., Vollenbroich, R., Deckarm, S., Gräni, C., Dobner, S., Stark, A. W., Erne, S. A., Babongo Bosombo, F., Fischer, K., Stortecky, S., Reusser, N., Fürholz, M., Siontis, G. C. M., Heg, D., Hunziker, L., Windecker, S., & Lanz, J. (2021). Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial. JAMA cardiology, 6(10), 1171-1176. https://doi.org/10.1001/jamacardio.2021.2247
Pilgrim, Thomas, et al. "Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial." JAMA cardiology vol. 6,10 (2021): 1171-1176. doi: https://doi.org/10.1001/jamacardio.2021.2247
Pilgrim T, Vollenbroich R, Deckarm S, Gräni C, Dobner S, Stark AW, Erne SA, Babongo Bosombo F, Fischer K, Stortecky S, Reusser N, Fürholz M, Siontis GCM, Heg D, Hunziker L, Windecker S, Lanz J. Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2021 Oct 01;6(10):1171-1176. doi: 10.1001/jamacardio.2021.2247. PMID: 34259826; PMCID: PMC8281020.
Copy
Download .nbib